Repligen | RGEN - Despesas Operacionais

Preço das Ações
110.12
Mudança Diária
-4.30 -3.76%
Mensal
-11.88%
Anual
-17.46%
Q1 Previsão
106.82




Despesas Operacionais Alterar Data
Agilent USD 1.44B 27M 2025-12
Align Technology USD 822.85M 11.8M 2025-12
Bio Techne USD 241.42M 2.52M 2025-12
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Bruker USD 900.9M 124.3M 2025-12
Charles River Laboratories USD 918.41M 2.49B 2025-12
Danaher USD 5.34B 45.74B 2025-12
Dentsply International USD 423M 1.06B 2025-12
General Electric Aerospace USD 10.94B 7.87B 2025-12
Henry Schein USD 3.25B 110M 2025-12
Illumina USD 903M 69M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Repligen USD 177.94M 1.82M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Standard Biotools USD 45.72M 2.7M 2025-12
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Waters USD 661.85M 1.67B 2025-12
West Pharmaceutical Services USD 642.5M 2.41B 2025-12